Q32 Bio Q1 2025 EPS $(0.90) Up From $(6.33) YoY, Cash And Cash Equivalents Of $65.5M As Of March 31, 2025 Expected To Provide Financial Runway Into 2H 2026

Benzinga
08 May

Q32 Bio Q1 2025 EPS $(0.90) Up From $(6.33) YoY, Cash And Cash Equivalents Of $65.5M As Of March 31, 2025 Expected To Provide Financial Runway Into 2H 2026

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10